ARTICLE | Financial News
Dukes joining OrbiMed
August 3, 2016 7:00 AM UTC
OrbiMed Advisors hired Iain Dukes as a venture partner. He was SVP of business development and licensing at Merck & Co. Inc. (NYSE:MRK). Before that, he was VP of external R&D at Amgen Inc. (NASDAQ:AMGN). ...